Categories: NewsPharmaceutical

Merck Foundation Announces $17 Million U.S. Initiative To Expand Access to High-Quality Cardiac Care

RAHWAY, NJ / ACCESSWIRE / November 20, 2024 / The Merck Foundation (Foundation) has announced a new initiative to help advance equitable access to high-quality, culturally responsive care for people with heart conditions in underserved U.S. communities-the Collaborative for Equity in Cardiac Care (Collaborative).

The Foundation is committing $17 million over five years (2025-2030) to support the Collaborative, which aims to:

  • Transform the delivery of primary care by promoting person-centered approaches to meet the medical and social needs of people living with heart conditions;

  • Build sustainable community partnerships to address barriers to cardiac care;

  • Improve health outcomes and quality of life for people living with heart conditions;

  • Disseminate findings and lessons learned to improve the delivery of cardiac care.

In underserved communities across the U.S., people with heart conditions encounter more barriers to timely diagnoses, receive a lower quality of care and experience poorer health outcomes than those living in other parts of the country. These disparities are often fueled by social drivers of health, such as a lack of access to stable housing, transportation, education, nutritious foods and employment opportunities.

To apply to join the Collaborative and help address inequities in cardiac care, an organization must be designated as a qualified 501(c)(3) non-profit organization and submit a letter of intent to cardiaccareequity@rabinmartin.com by Jan.10, 2025. For more information, please click here to view the Collaborative’s call for proposals.

About the Merck Foundation

The Merck Foundation (Foundation) is a U.S.-based, private charitable organization. Established in 1957 by Merck, a leading global biopharmaceutical company, the Foundation is funded entirely by the company and is Merck’s chief source of funding support to qualified non-profit charitable organizations. Since its inception, the Foundation has contributed more than $1 billion to support important initiatives that address critical global health and societal needs that are consistent with Merck’s purpose: to save and improve lives around the world. For more information, visit merck.com/company-overview/sustainability/philanthropy/merck-foundation.

View additional multimedia and more ESG storytelling from Merck & Co., Inc. on 3blmedia.com.

Contact Info:

Spokesperson: Merck & Co., Inc.
Website: https://www.3blmedia.com/profiles/merck-co-inc
Email: info@3blmedia.com

SOURCE: Merck & Co., Inc.

View the original press release on accesswire.com

Staff

Recent Posts

Daily Fit Notes Rolls Out Affordable Fitness Solutions for the Modern Lifestyle

Daily Fit Notes, founded by Justin Brey in New York, launches a text-based subscription fitness…

24 hours ago

WillowWood Rebrand by DD.NYC Wins Gold Anthem Award for Product and Innovation in 2024 Rebrand

MT. STERLING, Ohio, Dec. 20, 2024 /PRNewswire/ -- WillowWood, a global leader in prosthetic solutions,…

1 day ago

Quantum Biopharma Announces Closing of Second Tranche

TORONTO, ON / ACCESSWIRE / December 20, 2024 / Quantum BioPharma Ltd. (NASDAQ:QNTM)(CSE:QNTM)(FRA:0K91) ("Quantum BioPharma"…

1 day ago

Glow Lifetech Announces Completion of Final Payment under Swiss Pharma Share Exchange Agreement and Debt Settlement

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Glow Lifetech Corp. (CSE: GLOW) (OTC Pink:…

2 days ago

Bloom Burton & Co. Inc. Announces Changes to Holdings in Satellos Bioscience Inc.

Toronto, Ontario--(Newsfile Corp. - December 20, 2024) - Bloom Burton & Co. Inc. (Bloom Burton)…

2 days ago